BRPI0417520A - 1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilon - Google Patents
1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilonInfo
- Publication number
- BRPI0417520A BRPI0417520A BRPI0417520-4A BRPI0417520A BRPI0417520A BR PI0417520 A BRPI0417520 A BR PI0417520A BR PI0417520 A BRPI0417520 A BR PI0417520A BR PI0417520 A BRPI0417520 A BR PI0417520A
- Authority
- BR
- Brazil
- Prior art keywords
- carboxamides
- inhibitors
- casein kinase
- substituted
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"1H-PIRROLO¢3,2-B, 3,2-C, E 2,3-C!PIRIDINA-2-CARBOXAMIDAS SUBSTITUìDAS E ANáLOGOS RELATADOS COMO INIBIDORES DE CASEìNA CINASE I-EPSILON". A presente invenção descreve e reivindica 1H-pirrol¢3,2-b!piridina-2-carboxamidas substituídas, 1H-pirrol¢3,2-c!piridina-2-carboxamidas e 1H-pirrol¢2,3-c!piridina-2-carboxamidas (Compostos de fórmula (I)) como inibidores de caseína cinase lsym>humana, e métodos de emprego dos referidos compostos de fórmula (I) para tratar doenças do sistema nervoso central e distúrbios incluindo distúrbios do humor e distúrbios do sono. Composições farmacêuticas compreendendo compostos de fórmula (I) e métodos para a preparação de compostos de fórmula (I) são também descritos e reivindicados.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52876403P | 2003-12-11 | 2003-12-11 | |
PCT/US2004/040080 WO2005061498A1 (en) | 2003-12-11 | 2004-12-01 | Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0417520A true BRPI0417520A (pt) | 2007-03-06 |
Family
ID=34710096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0417520-4A BRPI0417520A (pt) | 2003-12-11 | 2004-12-01 | 1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilon |
Country Status (21)
Country | Link |
---|---|
US (2) | US7402672B2 (pt) |
EP (1) | EP1747220B1 (pt) |
JP (1) | JP4691506B2 (pt) |
KR (1) | KR20060113754A (pt) |
CN (1) | CN100439367C (pt) |
AT (1) | ATE428711T1 (pt) |
AU (1) | AU2004303826A1 (pt) |
BR (1) | BRPI0417520A (pt) |
CA (1) | CA2549183A1 (pt) |
DE (1) | DE602004020685D1 (pt) |
DK (1) | DK1747220T3 (pt) |
ES (1) | ES2324871T3 (pt) |
HK (1) | HK1098742A1 (pt) |
HR (1) | HRP20090380T1 (pt) |
IL (1) | IL175875A0 (pt) |
PL (1) | PL1747220T3 (pt) |
PT (1) | PT1747220E (pt) |
RS (1) | RS50823B (pt) |
SI (1) | SI1747220T1 (pt) |
TW (1) | TW200530234A (pt) |
WO (1) | WO2005061498A1 (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0514397A (pt) * | 2004-08-19 | 2008-06-10 | Aventis Pharma Inc | derivados de 3-ariltioindol-2-carboxamida e análogos destes como inibidores de caseìna cinase iépsilon |
JO2724B1 (en) | 2004-08-19 | 2013-09-15 | افينتس فارماسوتيكالز انك | 3-Alternative-5 -6-Amino Alkyl Indole-2-Carboxyl Acid Amide and Related Isotopes as Casein Kinase Inhibitors |
JO2629B1 (en) * | 2004-08-19 | 2012-06-24 | افينتيس فارما سوتيكالز انك | Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon |
JP2009507024A (ja) * | 2005-09-01 | 2009-02-19 | アレイ バイオファーマ、インコーポレイテッド | Raf阻害剤化合物およびその使用方法 |
WO2007048064A2 (en) * | 2005-10-21 | 2007-04-26 | Exelixis, Inc. | Amino-pyrimidines as casein kinase ii (ck2) modulators |
FR2918061B1 (fr) | 2007-06-28 | 2010-10-22 | Sanofi Aventis | Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique. |
FR2918986B1 (fr) | 2007-07-19 | 2009-09-04 | Sanofi Aventis Sa | Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique |
FR2939134A1 (fr) | 2008-12-01 | 2010-06-04 | Sanofi Aventis | Derives de 6-cycloamino-3-(1h-pyrrolo°2,3-b!pyridin-4-yl) imidazo°1,2-b!-pyridazine, leur preparation et leur application en therapeutique |
FR2940285A1 (fr) | 2008-12-19 | 2010-06-25 | Sanofi Aventis | Derives de 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo °1,2-b!-pyridazine et 6-cycloamino-2-furanyl-3- (pyridin-4-yl)imidazo°1,2-b!-pyridazine, leur preparation et leur application en therapeutique |
FR2940284B1 (fr) | 2008-12-19 | 2011-02-18 | Sanofi Aventis | Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique |
FR2945289A1 (fr) | 2009-05-11 | 2010-11-12 | Sanofi Aventis | Derives de 2-cycloamino-5-(pyridin-4-yl)imidazo°2,1-b! °1,3,4!thiadiazole, leur preparation et leur application en therapeutique |
IN2012DN03182A (pt) * | 2009-10-28 | 2015-09-25 | Pfizer | |
FR2960876B1 (fr) * | 2010-06-03 | 2012-07-27 | Sanofi Aventis | Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique. |
WO2014111871A1 (en) | 2013-01-17 | 2014-07-24 | Aurigene Discovery Technologies Limited | 4,5-dihydroisoxazole derivatives as nampt inhibitors |
WO2014182033A1 (en) * | 2013-05-08 | 2014-11-13 | Yuhan Corporation | Process for the preparation of pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof |
KR101657599B1 (ko) * | 2013-05-20 | 2016-09-19 | 주식회사유한양행 | 피롤로[2,3-c]피리딘 유도체 또는 이의 약학적으로 허용가능한 염의 제조방법 |
AR098414A1 (es) * | 2013-11-14 | 2016-05-26 | Bristol Myers Squibb Co | PIPERAZINAS DE PIRAZOLO SUSTITUIDO COMO INHIBIDORES DE CASEÍNA QUINASA 1 d/e |
CN104945313A (zh) * | 2015-06-19 | 2015-09-30 | 洪帅金 | 一种2-甲基-3-溴吡啶的制备方法 |
CN104974082A (zh) * | 2015-07-26 | 2015-10-14 | 陈吉美 | 一种2-甲基-4-溴吡啶的制备方法 |
CN105198802A (zh) * | 2015-11-03 | 2015-12-30 | 江苏梦得电镀化学品有限公司 | 一种2-甲基-3-溴吡啶的制备方法 |
US10973820B2 (en) | 2017-12-13 | 2021-04-13 | Facio Intellectual Property B.V. | Compounds for treatment of diseases related to DUX4 expression |
TW202112368A (zh) | 2019-06-13 | 2021-04-01 | 荷蘭商法西歐知識產權股份有限公司 | 用於治療有關dux4表現之疾病的抑制劑組合 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675332A (en) * | 1984-12-10 | 1987-06-23 | Warner-Lambert Company | Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents |
US5527819A (en) | 1991-09-06 | 1996-06-18 | Merck & Co., Inc. | Inhibitors of HIV reverse transcriptase |
PL175788B1 (pl) * | 1993-02-24 | 1999-02-26 | Merck & Co Inc | Amidowe pochodne indolu i zawierające je kompozycje farmaceutyczne |
US6075037A (en) | 1994-06-09 | 2000-06-13 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
US5977134A (en) | 1996-12-05 | 1999-11-02 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6432989B1 (en) * | 1999-08-27 | 2002-08-13 | Pfizer Inc | Use of CRF antagonists to treat circadian rhythm disorders |
DK1432707T3 (da) | 2001-10-02 | 2012-06-11 | Pharmacia & Upjohn Co Llc | Azabicyklisk-substituerede kondenserede heteroarylforbindelser til behandling af sygdomme |
AU2003220190A1 (en) | 2002-03-13 | 2003-09-29 | Pharmacia & Upjohn Company Llc | Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators |
JP2005527542A (ja) * | 2002-03-27 | 2005-09-15 | グラクソ グループ リミテッド | キノリンおよびアザインドール誘導体およびその5−ht6リガンドとしての使用 |
-
2004
- 2004-12-01 DE DE602004020685T patent/DE602004020685D1/de active Active
- 2004-12-01 US US11/001,533 patent/US7402672B2/en active Active
- 2004-12-01 CN CNB200480040577XA patent/CN100439367C/zh not_active Expired - Fee Related
- 2004-12-01 AT AT04812567T patent/ATE428711T1/de not_active IP Right Cessation
- 2004-12-01 RS RSP-2009/0302A patent/RS50823B/sr unknown
- 2004-12-01 PL PL04812567T patent/PL1747220T3/pl unknown
- 2004-12-01 JP JP2006543873A patent/JP4691506B2/ja not_active Expired - Fee Related
- 2004-12-01 SI SI200431149T patent/SI1747220T1/sl unknown
- 2004-12-01 PT PT04812567T patent/PT1747220E/pt unknown
- 2004-12-01 BR BRPI0417520-4A patent/BRPI0417520A/pt not_active IP Right Cessation
- 2004-12-01 DK DK04812567T patent/DK1747220T3/da active
- 2004-12-01 CA CA002549183A patent/CA2549183A1/en not_active Abandoned
- 2004-12-01 AU AU2004303826A patent/AU2004303826A1/en not_active Abandoned
- 2004-12-01 KR KR1020067013455A patent/KR20060113754A/ko not_active Application Discontinuation
- 2004-12-01 EP EP04812567A patent/EP1747220B1/en active Active
- 2004-12-01 WO PCT/US2004/040080 patent/WO2005061498A1/en active Application Filing
- 2004-12-01 ES ES04812567T patent/ES2324871T3/es active Active
- 2004-12-10 TW TW093138220A patent/TW200530234A/zh unknown
-
2006
- 2006-05-23 IL IL175875A patent/IL175875A0/en unknown
-
2007
- 2007-05-15 HK HK07105112.5A patent/HK1098742A1/xx not_active IP Right Cessation
-
2008
- 2008-04-21 US US12/106,681 patent/US7626027B2/en active Active
-
2009
- 2009-07-03 HR HR20090380T patent/HRP20090380T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
EP1747220B1 (en) | 2009-04-15 |
CA2549183A1 (en) | 2005-07-07 |
JP4691506B2 (ja) | 2011-06-01 |
EP1747220A1 (en) | 2007-01-31 |
US20050131012A1 (en) | 2005-06-16 |
WO2005061498A1 (en) | 2005-07-07 |
HK1098742A1 (en) | 2007-07-27 |
TW200530234A (en) | 2005-09-16 |
HRP20090380T1 (hr) | 2009-08-31 |
DE602004020685D1 (de) | 2009-05-28 |
ATE428711T1 (de) | 2009-05-15 |
JP2007513950A (ja) | 2007-05-31 |
RS50823B (sr) | 2010-08-31 |
US7402672B2 (en) | 2008-07-22 |
US7626027B2 (en) | 2009-12-01 |
CN100439367C (zh) | 2008-12-03 |
ES2324871T3 (es) | 2009-08-18 |
PL1747220T3 (pl) | 2009-09-30 |
AU2004303826A1 (en) | 2005-07-07 |
PT1747220E (pt) | 2009-07-08 |
CN1906194A (zh) | 2007-01-31 |
SI1747220T1 (sl) | 2009-08-31 |
IL175875A0 (en) | 2006-10-05 |
KR20060113754A (ko) | 2006-11-02 |
US20080200496A1 (en) | 2008-08-21 |
DK1747220T3 (da) | 2009-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0417520A (pt) | 1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilon | |
TW200621788A (en) | Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase Iε | |
CY1109558T1 (el) | Παραγωγα βενζο[d]αζεπινης για την θεραπεια νευρολογικων διαταραχων | |
DE602004007239D1 (de) | 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN | |
WO2008060907A3 (en) | Pyrrolo-pyridine kinase inhibitors | |
RS20050041A (en) | Azaindole kinase inhibitors | |
ES2354824T3 (es) | Pirazolo[1,5-a]pirimidinas útiles como inhibidores de proteínas cinasas. | |
ATE424402T1 (de) | Imidazopyridinverbindungen | |
NO20062139L (no) | Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister | |
AU4818000A (en) | Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands | |
BG108207A (en) | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors | |
WO2006007378A3 (en) | Pyrrolotriazine kinase inhibitors | |
MX2010006748A (es) | Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2. | |
BR0309463A (pt) | Derivados de 1,2,3,4,7,8-hexaidro-6h-[1,4]diazepino[6,7,1-ij]quinolina como agentes antipsicóticos e antiobesidade | |
WO2002000623A3 (en) | Aryl fused substituted 4-oxy-pyridines | |
BR0311436A (pt) | Derivados de 1-(aminoalquil)-3-sulfoni-lindol e -indazol como ligandos da 5-hidroxitriptamina-6 | |
ATE433450T1 (de) | Substituierte 1,4,8-triazaspiro 4.5 decan-2-on- verbindungen | |
WO2002079169A8 (en) | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
ATE367380T1 (de) | Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate | |
PT1165544E (pt) | 1,4-di-hidroindeno¬1,2-c|pirazoles substituidos como inibidores de tirosina-quinase | |
BRPI0514380A (pt) | amidas de ácido 5- e 6-amnoalquil indol-2-carboxìlico 3-substituìdo e análogos relacionados como inibidores de caseìna quinase i | |
BRPI0409570A (pt) | derivados de 3-benzidrilideno-8-aza-biciclo[3.2.1]octano com atividade receptora de opióides | |
BRPI0515830A (pt) | derivados de cromano e usos dos mesmos no tratamento de distúrbios do sistema nervoso central | |
GB0311349D0 (en) | Therapeutic agents, compositions, preparations and uses | |
WO2007026221A3 (en) | Improved methods for preparing benzofused heteroaryl amide derivatives of thienopyridines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25G | Requested change of headquarter approved |
Owner name: AVENTIS PHARMACEUTICALS, INC. (US) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070165509/RJ DE 23/11/2007. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |